ANALYST-DOWNGRADE filed Sep 14, 2026 at 09:05 ET
Wells Fargo double-downgraded Accenture (ACN) from Overweight to Equal-Weight on Sept 14, 2026, maintaining a $194 price target. The call comes from a firm with a 54% accuracy rate on 6,022 calls and a 3.5% average return. Consensus is mixed: 59% Buy (19 analysts) vs 41% Hold (13 analysts), with no Sell ratings. The mean price target is $183.59, median $185, with a wide range of $130–$275. Current price of $183.9 sits at the mean, implying Wells Fargo's $194 target offers only 5.5% upside. Over the past 30 days, there has been 1 downgrade and 0 upgrades, while EPS revisions are net negative (0 up vs 3 down for the current fiscal year). Insider selling is notable, with CFO Joel Unruch and another insider selling over $1.2M combined, and no insider buys. Short interest is elevated at 61.1% of volume, aligning with the bearish analyst signal. The convergence of a double downgrade, insider sales, and downward estimate revisions warrants a cautious stance on ACN.